Literature DB >> 21589621

10-Methyl-isoalloxazine 5-oxide from synchrotron powder diffraction data.

Jan Rohlíček, Radek Cibulka, Jana Cibulková, Jaroslav Maixner, Michal Hušák.   

Abstract

THE TITLE COMPOUND [SYSTEMATIC NAME: 10-methyl-benzo[g]pteridine-2,4(3H,10H)-dione 5-oxide], C(11)H(8)N(4)O(3), consists of a large rigid isoalloxazine group which is approximately planar (r.m.s. deviation = 0.037 Å). In the crystal, inter-molecular N-H⋯O hydrogen bonds link the mol-ecules into centrosymmetric dimers. Dimers related by translation along the c axis form stacks through π-π inter-actions [centroid-centroid distances = 3.560 (5) and 3.542 (5) Å]. Weak inter-molecular C-H⋯O inter-actions further consolidate the crystal packing.

Entities:  

Year:  2010        PMID: 21589621      PMCID: PMC3011510          DOI: 10.1107/S1600536810048932

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the preparation of the title compound, see: Yoneda et al. (1976 ▶). For background to flavins, see: Massey (2000 ▶), Palfey & Massey (1998 ▶); Müller (1991 ▶). For a description of the Cambridge Structural Database, see: Allen (2002 ▶). For the crystal structures of similar compounds, see: Wang & Fritchie (1973 ▶); Farn et al. (2007 ▶).

Experimental

Crystal data

C11H8N4O3 M = 244.21 Monoclinic, a = 13.8774 (6) Å b = 14.5321 (4) Å c = 4.9305 (2) Å β = 90.830 (3)° V = 994.22 (5) Å3 Z = 4 Synchrotron radiation λ = 0.8856 Å μ = 0.20 mm−1 T = 293 K cylinder, 20 × 1 mm

Data collection

ESRF Grenoble, BM20 diffractometer Specimen mounting: capilary Data collection mode: transmission Scan method: step 2θmin = 4.0°, 2θmax = 36.5°, 2θstep = 0.01°

Refinement

R p = 0.042 R wp = 0.056 R exp = 0.021 R Bragg = 0.06 R(F 2) = 0.060 χ2 = 7.129 3251 data points 73 parameters 57 restraints H-atom parameters not refined Data collection: ESRF SPEC (Certified Scientific Software, 2003 ▶); cell refinement: GSAS (Larson & Von Dreele, 1994 ▶); data reduction: CRYSFIRE (Shirley, 2000 ▶); program(s) used to solve structure: FOX (Favre-Nicolin & Černý, 2002 ▶); program(s) used to refine structure: GSAS; molecular graphics: Mercury (Macrae et al., 2006 ▶) and PLATON (Spek, 2009 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810048932/cv5002sup1.cif Rietveld powder data: contains datablocks I. DOI: 10.1107/S1600536810048932/cv5002Isup2.rtv Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C11H8N4O3Z = 4
Mr = 244.21F(000) = 504
Monoclinic, P21/aDx = 1.633 Mg m3
Hall symbol: -P 2yabSynchrotron radiation, λ = 0.8856 Å
a = 13.8774 (6) ŵ = 0.20 mm1
b = 14.5321 (4) ÅT = 293 K
c = 4.9305 (2) Åyellow
β = 90.830 (3)°cylinder, 20 × 1 mm
V = 994.22 (5) Å3
ESRF Grenoble, BM20 diffractometerData collection mode: transmission
Radiation source: synchrotronScan method: step
Specimen mounting: capilarymin = 4.0°, 2θmax = 36.5°, 2θstep = 0.01°
Least-squares matrix: full73 parameters
Rp = 0.04257 restraints
Rwp = 0.0560 constraints
Rexp = 0.021Hydrogen site location: inferred from neighbouring sites
RBragg = 0.06H-atom parameters not refined
R(F2) = 0.06000Weighting scheme based on measured s.u.'s
χ2 = 7.129(Δ/σ)max = 0.02
3251 data pointsBackground function: GSAS Background function number 1 with 20 terms. Shifted Chebyshev function of 1st kind 1: 1199.79 2: -234.522 3: -315.536 4: 152.956 5: 123.532 6: -246.657 7: 116.810 8: 83.9272 9: -107.809 10: -12.4938 11: 79.2500 12: -25.2804 13: -27.8174 14: 13.6120 15: 6.03858 16: -3.86487 17: 2.09281 18: 9.92947 19: -18.6000 20: 1.36657
Excluded region(s): nonePreferred orientation correction: March-Dollase AXIS 1 Ratio= 0.89956 h= 0.000 k= 0.000 l= 1.000 Prefered orientation correction range: Min= 0.85318, Max= 1.37377
Profile function: CW Profile function number 4 with 21 terms Pseudovoigt profile coefficients as parameterized in P. Thompson, D.E. Cox & J.B. Hastings (1987). J. Appl. Cryst.,20,79-83. Asymmetry correction of L.W. Finger, D.E. Cox & A. P. Jephcoat (1994). J. Appl. Cryst.,27,892-900. Microstrain broadening by P.W. Stephens, (1999). J. Appl. Cryst.,32,281-289. #1(GU) = 118.875 #2(GV) = 80.014 #3(GW) = 0.010 #4(GP) = 0.000 #5(LX) = 1.385 #6(ptec) = 0.00 #7(trns) = 0.00 #8(shft) = 0.0000 #9(sfec) = 0.00 #10(S/L) = 0.0005 #11(H/L) = 0.0142 #12(eta) = 0.0000 #13(S400 ) = 1.7E-01 #14(S040 ) = 1.8E-02 #15(S004 ) = 6.2E-01 #16(S220 ) = -4.6E-02 #17(S202 ) = 3.4E-01 #18(S022 ) = 1.6E-01 #19(S301 ) = -5.6E-01 #20(S103 ) = 7.9E-01 #21(S121 ) = 7.0E-02 Peak tails are ignored where the intensity is below 0.0001 times the peak Aniso. broadening axis 0.0 0.0 1.0
xyzUiso*/Ueq
N10.0773 (7)0.1443 (5)1.0053 (18)0.036 (6)*
C20.0483 (8)0.0827 (7)1.194 (3)0.075 (8)*
N30.0977 (7)−0.0028 (6)1.2303 (19)0.068 (6)*
C40.1784 (5)−0.0297 (5)1.0946 (14)0.028 (8)*
C4a0.2075 (5)0.0367 (5)0.8768 (14)0.049 (7)*
N50.2843 (7)0.0175 (6)0.725 (2)0.120 (8)*
C5a0.3110 (6)0.0833 (6)0.5319 (18)0.077 (9)*
C60.3917 (7)0.0645 (6)0.365 (2)0.037 (7)*
C70.4210 (6)0.1290 (8)0.180 (2)0.052 (7)*
C80.3703 (8)0.2112 (7)0.1520 (18)0.059 (8)*
C90.2917 (7)0.2332 (6)0.311 (2)0.054 (8)*
C9a0.2610 (6)0.1684 (6)0.5019 (18)0.045 (9)*
N100.1787 (7)0.1824 (7)0.6664 (19)0.078 (7)*
C10a0.1522 (5)0.1216 (5)0.8572 (14)0.046 (8)*
O11−0.0238 (7)0.1000 (7)1.338 (2)0.063 (5)*
O120.2230 (7)−0.1014 (5)1.1524 (17)0.037 (4)*
O130.3291 (8)−0.0597 (7)0.748 (2)0.100 (5)*
C140.1211 (10)0.2660 (9)0.619 (3)0.095 (9)*
H1N30.0746−0.04051.34660.0804*
H1C60.4250.00760.38160.0456*
H1C70.47580.11730.07180.0612*
H1C80.39060.2540.01880.0708*
H1C90.25970.29050.29010.0636*
H1C140.14880.30130.4790.114*
H2C140.1190.30130.7810.114*
H3C140.0570.2490.5670.114*
O11—C21.261 (16)N10—C9a1.425 (13)
C4—C4a1.503 (10)N3—C21.429 (14)
O12—C41.243 (11)N3—C41.370 (12)
C5a—C9a1.425 (12)N5—C5a1.403 (13)
O13—N51.287 (14)N5—C4a1.341 (12)
C5a—C61.426 (13)C10a—C4a1.455 (10)
N1—C10a1.321 (12)C14—H1C140.9500
C6—C71.374 (14)C14—H2C140.9500
N1—C21.356 (15)C14—H3C140.9500
C7—C81.392 (15)C6—H1C60.9500
N10—C10a1.346 (12)C7—H1C70.9500
C8—C91.390 (14)N3—H1N30.8600
N10—C141.471 (17)C8—H1C80.9500
C9—C9a1.402 (13)C9—H1C90.9500
Cg1···Cg2i3.56 (1)Cg1···Cg3i3.54 (1)
C2—N1—C10A117.3 (8)C8—C9—C9A118.2 (8)
C2—N3—C4125.5 (9)N10—C9A—C5A117.3 (8)
O13—N5—C4A121.3 (9)N10—C9A—C9122.7 (8)
O13—N5—C5A121.5 (9)C5A—C9A—C9120.0 (8)
C4A—N5—C5A117.2 (8)N1—C10A—N10116.6 (8)
C9A—N10—C10A122.3 (9)N1—C10A—C4A126.4 (7)
C9A—N10—C14117.8 (9)N10—C10A—C4A117.0 (7)
C10A—N10—C14120.0 (9)C2—N3—H1N3117
O11—C2—N1120.0 (10)C4—N3—H1N3117
O11—C2—N3119.1 (11)C5A—C6—H1C6120
N1—C2—N3120.9 (10)C7—C6—H1C6120
O12—C4—N3122.4 (8)C6—C7—H1C7120
O12—C4—C4A124.3 (7)C8—C7—H1C7120
N3—C4—C4A113.3 (7)C7—C8—H1C8118
N5—C4A—C4119.3 (7)C9—C8—H1C8119
N5—C4A—C10A124.2 (7)C8—C9—H1C9121
C4—C4A—C10A116.4 (6)C9A—C9—H1C9121
N5—C5A—C6118.6 (8)N10—C14—H1C14110
N5—C5A—C9A121.9 (8)N10—C14—H2C14110
C6—C5A—C9A119.5 (8)N10—C14—H3C14109
C5A—C6—C7119.7 (8)H1C14—C14—H2C14110
C6—C7—C8119.8 (9)H1C14—C14—H3C14109
C7—C8—C9122.8 (9)
D—H···AD—HH···AD···AD—H···A
N3—H1N3···O11ii0.861.922.764 (14)166
C14—H2C14···O12iii0.952.633.097 (16)111
C14—H1C14···O13iv0.952.333.194 (17)151
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N3—H1N3⋯O11i0.861.922.764 (14)166
C14—H2C14⋯O12ii0.952.633.097 (16)111
C14—H1C14⋯O13iii0.952.333.194 (17)151

Symmetry codes: (i) ; (ii) ; (iii) .

  4 in total

1.  The Cambridge Structural Database: a quarter of a million crystal structures and rising.

Authors:  Frank H Allen
Journal:  Acta Crystallogr B       Date:  2002-05-29

2.  Syntheses of isoalloxazines and isoalloxazine 5-oxides. A new synthesis of riboflavin.

Authors:  F Yoneda; Y Sakuma; M Ichiba; K Shinomura
Journal:  J Am Chem Soc       Date:  1976-02-04       Impact factor: 15.419

Review 3.  The chemical and biological versatility of riboflavin.

Authors:  V Massey
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

4.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.